Clock iconApril 14, 2021

Immediate Pause in the Administration of the Johnson and Johnson COVID-19 vaccine

The FDA is recommending an immediate pause in the administration of the Johnson and Johnson (Janssen) COVID-19 vaccine due reports of six cases of a rare and serious clot (cerebral venous sinus thrombosis)…there has been one associated death…for context, 6.8 million doses of the Johnson and Johnson COVID-19 vaccine have been administered…a link to the FDA statement is below.

Consequently, all CommonSpirit Health facilities should immediately halt administration of the Johnson and Johnson COVID-19 vaccine…there will be an emergency session of the Advisory Committee on Immunization Practices (ACIP) tomorrow (Wednesday, April 14) to review the data…additional guidance might be forthcoming after ACIP meets.

Please be sure all of your sites are aware of this development…our pharmacy and patient safety teams are working to provide additional information today.

Read the full story at the FDA Website.

Share

0 Comments

Add Comment

    There are currently no comments

Add a Comment

Your email address will not be published. Required fields are marked *

Keep My Post Anonymous

Notify me of new comments via email

I understand that all comments are moderated and subject to approval for posting